Antares Pharma Inc 's ability to collect accounts receivable sequentially worsen to 2.66, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Antares Pharma Inc 's Accounts Receivable average collection period in the Mar 31 2022 quarter, has increased to 137 days, from 116 days, in the Dec 31 2021 quarter.

If we take a look into Healthcare sector 569 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Mar 31 2022 from 1363 to 3543.

What is Receivable Turnover Ratio?
What is Antares Pharma Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

ATRS Receivables Turnover Ratio	(Mar 31 2022) I. Quarter	(Dec 31 2021) IV. Quarter	(Sep 30 2021) III. Quarter	(Jun 30 2021) II. Quarter	(Mar 31 2021) I. Quarter
Y / Y Receivable Change	95.94 %	96.6 %	28.15 %	58.12 %	36.7 %
Y / Y Revenue Change	-1.25 %	10.42 %	20.47 %	38.89 %	27.22 %
Receivable Turnover Ratio (TTM)	2.66	3.14	3.7	3.76	3.92
ATRS's Total Ranking	# 3543	# 1363	# 3008	# 1373	# 3534
Accounts Receivable average collection period days	137	116	99	97	93
Seq. Receivable Change	1.36 %	52.39 %	0.46 %	26.28 %	1.7 %
Seq. Revenue Change	-14.72 %	1.12 %	7.14 %	6.88 %	-4.65 %

Receivable Turnover Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 169
Healthcare Sector	# 570
Overall Market	# 3543

Receivable Turnover Ratio Statistics
High	Average	Low
9.18	5.49	2.66
(Jun 30 2015)		(Mar 31 2022)

ATRS Company Profile • Back to ATRS Efficiency Comparisons • Compare ATRS Receivables Turnover Ratio to its Competitors

Financial Statements
Antares Pharma Inc 's Accounts Receivable	$ 84 Millions	Visit ATRS's Balance sheet
Antares Pharma Inc 's Sales TTM	$ 183 Millions	Visit ATRS's Income Statement
Sources of ATRS's Revenues		Visit ATRS's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
ATRS's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
ATRS's Growth Rates	ATRS's Roa	ATRS's Inventory Turnover Ratio	ATRS's Dividend Comparisons
ATRS's Profitability Ratios	ATRS's Roi	ATRS's Asset Turnover Ratio	ATRS's Dividend Growth
ATRS's Valuation Ratios	ATRS's Roe	ATRS's Financial Strength Ratios	ATRS's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Mar 31 2022, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Mar 31 2022	Receivable at quarter ending Mar 31 2022
Absci Corp	5.98	$ 4.538 Millions	$ 0.759 Millions
Rxsight Inc	5.97	$ 28.051 Millions	$ 4.695 Millions
The Cooper Companies Inc	5.96	$ 3,139.500 Millions	$ 527.075 Millions
Neuropace Inc	5.95	$ 45.340 Millions	$ 7.617 Millions
Durect Corp	5.95	$ 13.680 Millions	$ 2.300 Millions
Volitionrx Limited	5.94	$ 0.179 Millions	$ 0.030 Millions
Titan Pharmaceuticals Inc	5.94	$ 1.036 Millions	$ 0.175 Millions
Capforce Inc	5.93	$ 3.946 Millions	$ 0.665 Millions
West Pharmaceutical Services Inc	5.93	$ 2,880.900 Millions	$ 486.150 Millions
Merck and Co Inc	5.92	$ 52,525.000 Millions	$ 8,868.000 Millions
Organogenesis Holdings Inc	5.92	$ 463.624 Millions	$ 78.322 Millions
Baxter International Inc	5.89	$ 13,545.000 Millions	$ 2,298.750 Millions
Iridex Corp	5.89	$ 54.921 Millions	$ 9.322 Millions
Nevro Corp	5.89	$ 386.137 Millions	$ 65.586 Millions
Precision Optics Corporation Inc	5.87	$ 13.558 Millions	$ 2.309 Millions
Revvity Inc	5.86	$ 5,018.922 Millions	$ 855.749 Millions
Penumbra Inc	5.86	$ 782.281 Millions	$ 133.510 Millions
Incyte Corporation	5.84	$ 3,114.784 Millions	$ 533.376 Millions
Cryoport inc	5.84	$ 221.626 Millions	$ 37.953 Millions
Conmed Corporation	5.82	$ 1,020.285 Millions	$ 175.382 Millions
Dentsply Sirona Inc	5.81	$ 4,164.000 Millions	$ 716.750 Millions
Medtronic Plc	5.78	$ 31,686.000 Millions	$ 5,480.250 Millions
Sharecare Inc	5.76	$ 423.916 Millions	$ 73.571 Millions
Q Biomed inc	5.76	$ 0.271 Millions	$ 0.047 Millions
American Bio Medica Corporation	5.75	$ 2.003 Millions	$ 0.348 Millions
Co diagnostics Inc	5.75	$ 100.560 Millions	$ 17.499 Millions
Maxcyte inc	5.74	$ 38.987 Millions	$ 6.796 Millions
Surgery Partners Inc	5.73	$ 2,308.900 Millions	$ 402.725 Millions
Lantheus Holdings Inc	5.69	$ 541.579 Millions	$ 95.141 Millions
Relay Therapeutics Inc	5.69	$ 2.496 Millions	$ 0.439 Millions

Date modified: 2026-08-29T17:23:07+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.